Hudson Edge Investment Partners Inc. Has $6.67 Million Holdings in HCA Healthcare, Inc. $HCA

Hudson Edge Investment Partners Inc. decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 19.5% during the second quarter, HoldingsChannel.com reports. The fund owned 17,418 shares of the company’s stock after selling 4,218 shares during the period. HCA Healthcare makes up 1.1% of Hudson Edge Investment Partners Inc.’s holdings, making the stock its 22nd largest position. Hudson Edge Investment Partners Inc.’s holdings in HCA Healthcare were worth $6,673,000 at the end of the most recent quarter.

A number of other institutional investors also recently modified their holdings of HCA. Brighton Jones LLC acquired a new position in HCA Healthcare in the 4th quarter valued at $1,021,000. Merit Financial Group LLC grew its position in shares of HCA Healthcare by 109.9% in the first quarter. Merit Financial Group LLC now owns 3,293 shares of the company’s stock valued at $1,138,000 after purchasing an additional 1,724 shares during the last quarter. RFG Advisory LLC acquired a new position in shares of HCA Healthcare during the 1st quarter worth about $204,000. Whipplewood Advisors LLC grew its holdings in HCA Healthcare by 95.1% in the 1st quarter. Whipplewood Advisors LLC now owns 201 shares of the company’s stock valued at $69,000 after buying an additional 98 shares during the last quarter. Finally, Ullmann Wealth Partners Group LLC boosted its position in shares of HCA Healthcare by 1.3% in the first quarter. Ullmann Wealth Partners Group LLC now owns 6,890 shares of the company’s stock valued at $2,381,000 after acquiring an additional 88 shares during the period. Institutional investors own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares of the company’s stock, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.30% of the stock is currently owned by corporate insiders.

HCA Healthcare Stock Up 0.2%

Shares of HCA Healthcare stock opened at $426.81 on Friday. The stock has a market capitalization of $99.87 billion, a P/E ratio of 17.94, a price-to-earnings-growth ratio of 1.34 and a beta of 1.40. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $429.43. The company has a 50-day simple moving average of $395.62 and a 200 day simple moving average of $371.70.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion during the quarter, compared to analyst estimates of $18.49 billion. During the same quarter last year, the business posted $5.50 earnings per share. The company’s revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Investors of record on Tuesday, September 16th were issued a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, September 16th. HCA Healthcare’s payout ratio is currently 12.11%.

Analysts Set New Price Targets

A number of analysts have weighed in on the stock. Wells Fargo & Company reduced their price target on shares of HCA Healthcare from $385.00 to $375.00 and set an “equal weight” rating for the company in a report on Thursday, August 14th. Barclays lifted their target price on HCA Healthcare from $390.00 to $445.00 and gave the stock an “overweight” rating in a research report on Thursday, September 18th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $444.00 price objective on shares of HCA Healthcare in a research report on Tuesday, August 26th. Morgan Stanley cut their target price on HCA Healthcare from $410.00 to $400.00 and set an “equal weight” rating for the company in a research note on Monday, July 28th. Finally, Wolfe Research lowered shares of HCA Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $407.75.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.